IN BRIEF: EMV Capital "optimistic" after annual AuM and revenue growth
19th May 2026 18:17
EMV Capital PLC - life sciences-focused investor - Reports results for 2025. Assets under management totals GBP112.5 million as at December 31, up from GBP98.5 million one year prior. Group revenue increases 17% to GBP2.9 million from GBP2.5 million the year before, "driven by higher corporate finance fees, increased fundraising activity and higher recurring fund management fees following the full operational integration of Martlet Capital." Core revenue increases 31% to GBP3.2 million from GBP2.4 million. Pretax loss narrows to GBP685,000 from GBP3.7 million. EMV says syndicated fundraising during the period totalled GBP12.0 million across 14 portfolio companies, up from GBP10.6 million across 12 companies. Read More